A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer.
about
Asymmetric RNA Distribution among Cells and Their Secreted Exosomes: Biomedical Meaning and Considerations on Diagnostic Applications.Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer.Machine learning to detect signatures of disease in liquid biopsies - a user's guide.Exosome Theranostics: Biology and Translational Medicine.Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol.Exosomal proteins as potential markers of tumor diagnosis.Insights into the Proteome of Gastrointestinal Stromal Tumors-Derived Exosomes Reveals New Potential Diagnostic Biomarkers.Characterization and selective incorporation of small non-coding RNAs in non-small cell lung cancer extracellular vesicles.MicroRNAs as biomarkers for clinical studies.Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications.Validation of Biomarkers for Early Detection of Pancreatic Cancer: Summary of The Alliance of Pancreatic Cancer Consortia for Biomarkers for Early Detection Workshop.KRAS induces lung tumorigenesis through microRNAs modulation.Pancreatic cancer and associated exosomes.MiR-21-mediated Metabolic Alteration of Cancer-associated Fibroblasts and Its Effect on Pancreatic Cancer Cell Behavior.Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden.Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma.The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic Cancer
P2860
Q42372780-61777A38-0560-4056-A874-C9593DCFD53BQ43155431-0D6EC32A-B80A-442D-90E1-0F954DEC4F1CQ45943388-04AB2BEB-900F-42BC-A862-88AABE1ABC40Q47095746-6F327F8B-0253-482A-8A87-98B7E1D16A81Q47109593-C47B839C-EE1B-4F19-84B7-E663E8DE04CFQ47159665-A85E862A-690B-48AD-B128-0806E37A8050Q47292108-419C13B7-D83F-4CED-9362-952CCDC11BC1Q47654250-B8E91895-6CC9-475A-B8F1-31EC4FDB9C2FQ47947610-648FAF2A-55A7-4425-8DD3-1469EBCD3C65Q48301473-82D1A6B6-D2A8-4B5D-8BF9-737B18F08C4DQ49966087-27A805A5-5BEA-4572-A4F9-658B9782E66AQ50025863-FA149A6B-7CE1-40F1-9462-AF35C815CA14Q50075097-5FCC665D-BE87-42E3-A6EF-B4DE4478553DQ50282306-92803C70-C7EF-4B1A-8D34-D096126BAE88Q52714362-EF5BAE2E-BC26-406B-834C-A2D8264EE8EBQ55424250-C5D03964-724A-4269-B48F-997656E397DBQ55443866-3A901412-C588-41AC-8252-1B94D7024120Q58708604-F2E30250-BE75-4912-AB24-D8C152D24378
P2860
A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A microRNA signature in circul ...... diagnosing pancreatic cancer.
@en
A microRNA signature in circul ...... diagnosing pancreatic cancer.
@nl
type
label
A microRNA signature in circul ...... diagnosing pancreatic cancer.
@en
A microRNA signature in circul ...... diagnosing pancreatic cancer.
@nl
prefLabel
A microRNA signature in circul ...... diagnosing pancreatic cancer.
@en
A microRNA signature in circul ...... diagnosing pancreatic cancer.
@nl
P2093
P2860
P1433
P1476
A microRNA signature in circul ...... diagnosing pancreatic cancer.
@en
P2093
Michael House
Murray Korc
Samantha Deitz McElyea
Stuart Sherman
Xianyin Lai
P2860
P356
10.1016/J.CANLET.2017.02.019
P407
P577
2017-02-20T00:00:00Z